Nanjing Vishee Medical Technology Co Ltd (688580) — Capital Reinvestment Ratio

Latest as of September 2025: 0.75x

Nanjing Vishee Medical Technology Co Ltd (688580) has a Capital Reinvestment Ratio of 0.75x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥42.79 Million) in capital expenditures (CN¥32.24 Million). See Nanjing Vishee Medical Technology Co Ltd (688580) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.75x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥42.79 Million
CNY

Capital Expenditures

CN¥32.24 Million
CNY

Data as of

Sep 2025
Most recent filing

Nanjing Vishee Medical Technology Co Ltd Capital Reinvestment Ratio (2013–2025)

This chart tracks Nanjing Vishee Medical Technology Co Ltd's Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for Nanjing Vishee Medical Technology Co Ltd (2013–2025)

Year-by-year Capital Reinvestment Ratio for Nanjing Vishee Medical Technology Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Nanjing Vishee Medical Technology Co Ltd stock valuation.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.67x CN¥176.74 Million CN¥118.12 Million ▼ -30.1%
2024 0.96x CN¥118.29 Million CN¥113.08 Million ▼ -3.9%
2023 0.99x CN¥134.20 Million CN¥133.48 Million ▼ -10.4%
2022 1.11x CN¥86.17 Million CN¥95.61 Million ▲ +99.9%
2021 0.56x CN¥157.37 Million CN¥87.34 Million ▲ +475.2%
2020 0.10x CN¥120.76 Million CN¥11.65 Million ▼ -35.7%
2019 0.15x CN¥141.47 Million CN¥21.23 Million ▼ -68.5%
2018 0.48x CN¥85.84 Million CN¥40.90 Million ▲ +71.5%
2017 0.28x CN¥52.35 Million CN¥14.55 Million ▼ -50.4%
2016 0.56x CN¥30.98 Million CN¥17.36 Million ▲ +36.3%
2015 0.41x CN¥25.22 Million CN¥10.37 Million ▼ -43.4%
2014 0.73x CN¥15.01 Million CN¥10.90 Million ▲ +138.3%
2013 0.30x CN¥8.23 Million CN¥2.51 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow